Skip to content

Japanese CTO PCI Expert Registry

Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01889459
Enrollment
19000
Registered
2013-06-28
Start date
2013-07-31
Completion date
2027-12-31
Last updated
2013-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Total Occlusion of Coronary Artery

Brief summary

The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.

Interventions

None listed

Sponsors

Japanese CTO PCI Expert Registry investigators
CollaboratorUNKNOWN
Kurashiki Central Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients eligible for PCI Patients who underwent PCI for CTO lesions that contain the following: 1. Thrombolysis in myocardial infarction trial (TIMI) 0 2. The occlusive period more than 3 months or unknown 3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft

Exclusion criteria

Patients ineligible for PCI judged in clinical practice

Design outcomes

Primary

MeasureTime frameDescription
successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-upwithin the first 1 month (plus 1 month) after PCI and during the 5-year follow-upearly and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan

Countries

Japan

Contacts

Primary ContactKeiko Oka
cto.e.registry@gmail.com81-86-422-0210
Backup ContactHarumi Katoh, MD, PhD
hk10731@kchnet.or.jp81-86-422-0210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026